TPX-115

Tego Science, Inc. · Phase 2 active Biologic

At a glance

Generic name	TPX-115
Sponsor	Tego Science, Inc.
Modality	Biologic
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy and Safety Study of TPX-115 on Partial-thickness Rotator Cuff Tear (PHASE2)
Safety Study of TPX-121 on Nasolabial Folds (PHASE1)
A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear (PHASE2, PHASE3)
Phase 1/2 Clinical Study of TPX-115 in Patients With Partial-Thickness Rotator Cuff Tear (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TPX-115 CI brief — competitive landscape report
TPX-115 updates RSS · CI watch RSS
Tego Science, Inc. portfolio CI